The Latest Cardiac and Vascular News
SAN FRANCISCO–(BUSINESS WIRE)–Element Science, an innovative health technology company developing a pioneering digital wearable platform for high-risk cardiovascular patients, announced the appointment of Lee Smith Jr. as the company’s first Head of Commercial. With nearly 20 years of successful leadership experience in sales, commercial operations, and customer success, Mr. Smith […]
TEL AVIV, Israel & ZURICH, & NEW YORK–(BUSINESS WIRE)–SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) (“SHL” or the “Company“), a leading provider and developer of advanced personal telemedicine solutions, is thrilled to announce that it recently officially launched it’s SmartHeart® membership program in the US. “The official launch marks a […]
PARIS–(BUSINESS WIRE)–Elixir Medical, a developer of transformative technologies to treat cardiovascular and peripheral disease, today announced that the PINNACLE I study evaluating the safety and performance of its LithiX™ Hertz Contact Intravascular Lithotripsy System (IVL) for treatment of moderate to severely calcified coronary artery lesions met its primary safety and […]
BOSTON, May 16, 2024 /PRNewswire/ — Heart Rhythm Society (HRS) Conference — Circle Cardiovascular Imaging Inc. and inHEART Inc. announced today a global distribution agreement enabling Circle to promote and market inHEART’s advanced, AI-enabled digital twin of the heart through Circle’s…
Promising results from the EMAGINE randomized trial suggest that treatment with BRAIN.Q’s AI-powered low electromagnetic field stimulation, aimed at enhancing the brain’s ability to relearn processes lost after a stroke, may help patients regain ‘freedom from disability’ with greater…
With these latest studies, the firmly established European market leader in stroke AI imaging adds to its growing body of evidence. The latest research reflects the company’s extensive academic collaborations and its growing Life Science partnerships. OXFORD, England and CHICAGO, May 16,…
Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial
COPENHAGEN, Denmark, May 16, 2024 /PRNewswire/ — Globally, cardiovascular diseases due to atherosclerosis – the build-up of plaque in arteries – are the leading cause of death. A new Danish-Spanish research collaboration aims to develop methods to detect atherosclerosis at earlier ages…
Real-time Vessel Measurement Informs Physician Treatment Decisions SAN DIEGO, May 15, 2024 /PRNewswire/ — Provisio Medical, Inc., pioneers of Sonic Lumen Tomography™ (SLT) technology to provide real-time blood vessel measurements during vascular interventions, today announced the…
HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology (“Pulse”), today announced enhancements to its executive leadership team to support its next pivotal phase of growth. “Together with Burke’s expertise and Kevin leading as Chief Commercial Officer, Pulse Biosciences is […]
